MedAdvisory vs OneRx
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
MedAdvisory
Facilitates real-time communication for gathering instant insights on drugs, diseases, tests, and treatments. This quick chat platform is ideal for market research, medical professionals, and students.
- Real-time communication
- Opinion leader insights
- Drug and disease discussions
- Test and trial data
- Diagnosis and treatment discussions
- Customizable chat platform
Read full descriptionHide full description
MedAdvisory is an iOS App, a one stop solution for real-time communication between internal & external stakeholders; gather instant Opinion Leader Inputs/insights on drugs and diseases, tests and trials, diagnosis and treatment, data and discussions in medicine. It is a Quick and easy chat platform for pharma or any other market research, students, doctors, others; customizable to match with company culture, image, reputation, branding
OneRx
An AI-powered medical assistant for clinicians, providing evidence-based summaries and research findings at the point of care. It helps doctors access reliable information to support clinical decisions, compare treatments, and improve confidence in everyday practice.
- AI-powered clinical decision support
- Evidence-based summaries
- Access to peer-reviewed research
- Treatment option comparisons
- Clear citations and references
- Improved speed and confidence in decision-making
Read full descriptionHide full description
OneRx — Your Evidence AI for Clinical Decision Support OneRx is an AI-powered medical evidence assistant designed to help clinicians access fast, reliable, and reference-backed information at the point of care. It brings together peer-reviewed research, standard guidelines, and structured clinical reasoning to support better-informed decisions. With OneRx, clinicians can: • Ask clinical questions and receive structured, evidence-based summaries • Access research findings from trusted, publicly available sources • Review treatment options, toxicity profiles, contraindications, and monitoring needs • Get simplified comparisons of therapies and relevant clinical considerations • Use clear citations and transparent reference lists • Improve the speed and confidence of everyday clinical decision-making OneRx is built to assist—not replace—professional medical judgment. It is designed for doctors, researchers, and medical teams who need quick access to high-quality information while staying aligned with evidence-based care.
Screenshots
Verdict
The clearest difference is iOS requirement: MedAdvisory at 10.0 against OneRx's 15.1. On price, review sentiment, update cadence and ads there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
MedAdvisory ships an update every 8 days, OneRx weekly. The most recent releases landed on November 2, 2026 and November 5, 2026 respectively.
| Parameter | MedAdvisory | OneRx |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (2 ratings) — better | — |
| Positive reviews | 100.0% of reviews | 100.0% of reviews |
| Number of ratings | 2 — better | — |
| Update frequency | Every 8 days | Weekly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 10.0 — better | 15.1 |
| Further details — not scored | ||
| Size | 94 MB | 41 MB |
| Age rating | 12+ | 17+ |
| Developer | MedSphere Corp | Originbluy Private Limited |
Customer experience
MedAdvisory
OneRx
In-app purchases
MedAdvisory
No in-app purchases
OneRx
No in-app purchases









